These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17673497)

  • 21. The role of the renin-angiotensin system in the pathophysiology, prevention, and treatment of renal impairment in patients with the cardiometabolic syndrome or its components.
    Alpert MA; Govindarajan G; Del Rosario ML; Reisin E
    J Cardiometab Syndr; 2009; 4(1):57-62. PubMed ID: 19245518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A call to action on World Kidney Day, 8 March 2007.
    Couser WG; Shah S; Kopple J; Beerkens P; Wilson A; Feehally J; Reiser T; Riella M
    Nephrology (Carlton); 2007 Feb; 12(1):1-2. PubMed ID: 17295652
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of pre-disease risk factors within metabolic syndrome on all-cause and cardiovascular disease mortality.
    Tsai SP; Wen CP; Chan HT; Chiang PH; Tsai MK; Cheng TY
    Diabetes Res Clin Pract; 2008 Oct; 82(1):148-56. PubMed ID: 18757109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes.
    Ryu S; Chang Y; Woo HY; Lee KB; Kim SG; Kim DI; Kim WS; Suh BS; Jeong C; Yoon K
    Am J Kidney Dis; 2009 Jan; 53(1):59-69. PubMed ID: 18838200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obesity, insulin resistance and kidney disease risk: insights into the relationship.
    Sarafidis PA
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):450-6. PubMed ID: 18695384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cardiovascular disease increases the risk of renal failure].
    Stenvinkel P
    Lakartidningen; 2007 Sep 5-11; 104(36):2495. PubMed ID: 17939437
    [No Abstract]   [Full Text] [Related]  

  • 27. The metabolic syndrome: definition, diagnosis and management.
    Novo S; Balbarini A; Belch JJ; Bonura F; Clement DL; Diamantopoulos E; Fareed J; Norgren L; Poredos P; Rotzocil K; ; ;
    Int Angiol; 2008 Jun; 27(3):220-31. PubMed ID: 18506125
    [No Abstract]   [Full Text] [Related]  

  • 28. Psoriasis comorbidities.
    Gottlieb AB; Chao C; Dann F
    J Dermatolog Treat; 2008; 19(1):5-21. PubMed ID: 18273720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between chronic kidney disease prevalence and end-stage renal disease risk.
    Hallan SI; Vikse BE
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):286-91. PubMed ID: 18408480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early referral in chronic kidney disease: an enormous opportunity for prevention.
    Powe NR
    Am J Kidney Dis; 2003 Feb; 41(2):505-7. PubMed ID: 12552517
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolic syndrome and the menopause.
    Kaaja RJ
    Menopause Int; 2008 Mar; 14(1):21-5. PubMed ID: 18380957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults.
    Tozawa M; Iseki C; Tokashiki K; Chinen S; Kohagura K; Kinjo K; Takishita S; Iseki K
    Hypertens Res; 2007 Oct; 30(10):937-43. PubMed ID: 18049025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for the development and progression of renal diseases in disadvantaged populations: role of the renin-angiotensin system blockade.
    Maione A; Strippoli GF
    Ethn Dis; 2009; 19(1 Suppl 1):S1-86-9. PubMed ID: 19484883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Kidney transplantation and life-style related diseases].
    Nishi S; Gejyo F; Saito K; Takahashi K
    Nihon Jinzo Gakkai Shi; 2004; 46(8):792-7. PubMed ID: 15645735
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiovascular risk and the urological patient.
    Kirby M; Kirby R
    BJU Int; 2009 Nov; 104(9):1185-6. PubMed ID: 19583722
    [No Abstract]   [Full Text] [Related]  

  • 36. Risk of development of chronic kidney disease in patients with type 2 diabetes having metabolic syndrome.
    Moin S; Gondal GM; Bano U
    J Coll Physicians Surg Pak; 2008 Aug; 18(8):472-6. PubMed ID: 18798582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of white blood cell count with metabolic syndrome in patients undergoing peritoneal dialysis.
    Park JT; Chang TI; Kim DK; Choi HY; Lee JE; Kim HW; Chang JH; Park SY; Kim E; Yoo TH; Han DS; Kang SW
    Metabolism; 2009 Oct; 58(10):1379-85. PubMed ID: 19501862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does the metabolic syndrome add to the diagnosis and treatment of cardiovascular disease?
    de Zeeuw D; Bakker SJ
    Nat Clin Pract Cardiovasc Med; 2008 Jul; 5 Suppl 1():S10-4. PubMed ID: 18580860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease?
    Bagby SP
    J Am Soc Nephrol; 2004 Nov; 15(11):2775-91. PubMed ID: 15504931
    [No Abstract]   [Full Text] [Related]  

  • 40. [The kidneys and the heart].
    Mann J; Hilgers KF; Veelken R; Kunz R
    Dtsch Med Wochenschr; 2008 Sep; 133(37):1839-43. PubMed ID: 18770484
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.